NDC 67296-2129

Moxifloxacin 5 mg per 1 mL solution/ drops

On the label: RedPharm Drug. Inc.. It's repackaged: RedPharm Drug. Inc. rebottles it from Lupin Pharmaceuticals, Inc.'s NDC 68180-422.

Where the pills inside were made

Factory	Where	Role	Last FDA inspection
Lupin Limited	Pithampur, India	Makes it and packages it	Serious problems, FDA actionJul 17, 2025 · 6 inspections, 4 with FDA action

Feb 26, 2019 · Class III · Lupin Pharmaceuticals Inc.
Failed Impurities/Degradation Specifications: Expansion of July 2018 and February 2019 recall due to high out-of-specification for impurities.
Lots: Lots: H701618, H701619, H701620, Exp March 2019; H702220, H702221, H702222, H702223, H702224, H702225, H702351, Exp April 2019; H702971, H702972, H702973, H702974, H703151, H703152, H703153, Exp June 2019; H703155, H703682, H703683, Exp July 2019; H704243, H704245, H704247, Exp September 2019; H704…
Feb 1, 2019 · Class III · Lupin Pharmaceuticals Inc.
Failed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained.
Lots: Lot Numbers: H705562, H705563, EXP. 11/2019; H800616, EXP. 01/2020
Jul 26, 2018 · Class III · Lupin Pharmaceuticals Inc.
Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study.
Lots: Lot #: H800393, Exp. 01/2020

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Generic drug: Moxifloxacin: every company that makes it
Form: solution/ drops, ophthalmic
Strength: 5 mg per 1 mL
Approval: ANDA ANDA202867
On the market since: Jul 1, 2017
Package NDCs: 67296-2129-3
Official label: DailyMed (National Library of Medicine), updated Dec 23, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?